Considering that the effector HBV-specific CD8+ T cells are gradually depleted during long-term HBV infection, eventually weakening the tumor surveillance of the adaptive immune system and thus leading to immune evasion by cancer cells, thereby promoting the progression of tumorigenesis. Here, CD8A is linked to cancer.